Discontinuation report INTEGRILIN
| Report ID | 155794 |
| Drug Identification Number | 02240352 |
| Brand name | INTEGRILIN |
| Common or Proper name | eptifibatide injection |
| Company Name | MERCK CANADA INC |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | EPTIFIBATIDE |
| Strength(s) | 2MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS |
| Packaging size | 20 mg/10 mL bolus vial - Fiole de 20 mg/10 mL pour bolus |
| ATC code | B01AC |
| ATC description | ANTITHROMBOTIC AGENTS |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | 2022-10-18 |
| Actual discontinuation date | 2022-10-17 |
| Remaining supply date | 2022-10-18 |
| Discontinuation status | Discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 16750 ROUTE TRANSCANADIENNE KIRKLAND, QUEBEC CANADA H9H 4M7 |
| Company contact information | 1-800-567-2594 medinfocanada@merck.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v14 | 2024-02-14 | French | Compare |
| v13 | 2022-11-18 | French | Compare |
| v12 | 2022-10-18 | French | Compare |
| v11 | 2022-10-18 | English | Compare |
| v10 | 2022-10-14 | French | Compare |
| v9 | 2022-10-14 | English | Compare |
| v8 | 2022-09-26 | French | Compare |
| v7 | 2022-09-26 | English | Compare |
| v6 | 2022-09-26 | French | Compare |
| v5 | 2022-09-26 | English | Compare |
| v4 | 2022-05-10 | French | Compare |
| v3 | 2022-05-10 | English | Compare |
| v2 | 2022-03-01 | French | Compare |
| v1 | 2022-03-01 | English | Compare |
Showing 1 to 14 of 14